Komori
Dts (9682) · InitiativeAdvanced

R&D for Competitive Solutions

First written in FY2016. 22 of 28 entries say "Restated". Latest entry: FY2026.

28entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2018-Q1 – FY2021-Q3RestatedFY2022-Q2 – FY2023-Q3RestatedFY2024-Q2 – FY2025-H12016: 120162017: 420172018: 320182019: 320192020: 320202021: 320212022: 320222023: 320232024: 220242025: 220252026: 12026
Same theme, other companies
Strengthening New Product and Technology Development Capabilities Through R&D and Basic ResearchA theme 216 companies write about · 0 as a headwind · 228 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 190 companies compared. The sentences above are computed from all 190.Comparing 200 of the theme's 228 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Total R&D expenses for the current consolidated fiscal year were ¥428 million. Through verification of development methods using generative AI, the Company accumulated knowledge and prepared for implementation in the development process. The Company conducted R&D aimed at enhancing system operations and establishing a business platform that would serve as a new earnings pillar, in preparation for providing observability solutions.」

    R&D expenses increased from ¥168 million in the previous fiscal year to ¥428 million, and specific R&D themes included generative AI development, the next-generation RAMScope model, an appearance inspection simulator and AI-enabled observability.
  2. FY2026-H1RestatedAnnual report

    「The Group's total R&D expenses for the interim consolidated accounting period were ¥186 million. There were no material changes in the status of the Group's R&D activities during the interim consolidated accounting period.」

    ¥186 million in R&D expenses was recognized, and it was stated that there were no material changes in the status of R&D activities.
  3. FY2025AdvancedAnnual report

    「Total R&D expenses for the current consolidated fiscal year were ¥168 million. The main R&D activities by segment were as follows.」

    ¥168 million in R&D expenses was recognized, and specific R&D themes related to automotive and embedded systems, including the next-generation RAMScope, a WCET analysis tool and microTRACER, were advanced.
  4. FY2025-H1RestatedAnnual report

    「The Group's total R&D expenses for the interim consolidated accounting period were ¥73 million. There were no material changes in the status of the Group's R&D activities during the interim consolidated accounting period.」

    ¥73 million in R&D expenses was recognized, and it was stated that there were no material changes in R&D activities.
  5. FY2024-Q3RestatedAnnual report

    「The Group's total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥107 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」

    ¥107 million in cumulative third-quarter R&D expenses was recognized, and it was reconfirmed that there were no material changes in the status of R&D activities.
  6. FY2024-Q2RestatedAnnual report

    「The Group's total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥76 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」

    ¥76 million in cumulative second-quarter R&D expenses was recognized, and it was reconfirmed that there were no material changes in the status of R&D activities.
  7. FY2023AdvancedAnnual report

    「Total R&D expenses for the current consolidated fiscal year were ¥294 million. The main R&D activities by segment were as follows. The Company conducted R&D on new BI and IoT, research and demonstration testing for zero-trust security, and development and solutionization of a system to support field supervisors.」

    R&D expenses totaled ¥294 million, with specific R&D themes including new BI and IoT incorporating automated AI analysis, in-house demonstration testing of zero-trust security, and the development and sale of Walk in home CUMOE.
  8. FY2023-Q3RestatedAnnual report

    「The Group's total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥198 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」

    ¥198 million in R&D expenses was recognized, but it was stated that there were no material changes in the status of R&D activities.
  9. FY2023-Q2RestatedAnnual report

    「The Group's total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥149 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」

    ¥149 million in R&D expenses was recognized, and it was reconfirmed that there were no material changes in R&D activities.
  10. FY2023-Q1RestatedAnnual report

    「The Group's total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥55 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」

    ¥55 million in R&D expenses was recognized, but it was stated that there were no material changes in the status of R&D activities.
  11. FY2022-Q3RestatedAnnual report

    「The Group's total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥129 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」

    ¥129 million in R&D expenses was recognized, but it was stated that there were no material changes in the status of R&D activities.
  12. FY2022-Q2RestatedAnnual report

    「The Group's total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥65 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」

    ¥65 million in R&D expenses was recognized, and it was reconfirmed that there were no material changes in R&D activities.
  13. FY2021AdvancedAnnual report

    「Total R&D expenses for the current consolidated fiscal year were ¥133 million. The main R&D activities by segment were as follows.」

    ¥133 million in R&D expenses was recognized, and R&D and demonstration testing progressed on a health-promotion app, remote conferencing, AI-Chatbot, monitoring and recording equipment for broadcasters, adviceReboot, RPA and contactless solutions, among other areas.
  14. FY2021-Q3RestatedAnnual report

    「The Group's total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥107 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」

    ¥107 million in cumulative third-quarter R&D expenses was recognized, and it was reconfirmed that there were no material changes in the status of R&D activities.
  15. FY2021-Q2RestatedAnnual report

    「The Group's total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥72 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」

    Cumulative second-quarter R&D expenses were ¥72 million, and it was stated that there were no material changes in the status of R&D activities.
  16. FY2021-Q1RestatedAnnual report

    「The Group's total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥37 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」

    ¥37 million in R&D expenses was recognized, and it was stated that there were no material changes in the status of R&D activities.
  17. FY2020-Q3RestatedAnnual report

    「The Group's total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥246 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」

    ¥246 million in R&D expenses was recognized, and it was reconfirmed that there were no material changes in the status of R&D activities.
  18. FY2020-Q2RestatedAnnual report

    「The Group's total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥162 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」

    ¥162 million in R&D expenses was recognized, and it was reconfirmed that there were no material changes in the status of R&D activities.
  19. FY2020-Q1RestatedAnnual report

    「The Group's total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥83 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」

    ¥83 million in R&D expenses was recognized, and it was stated that there were no material changes in the status of R&D activities.
  20. FY2019-Q3RestatedAnnual report

    「The Group's total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥339 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」

    ¥339 million in R&D expenses was recognized, and it was stated that there were no material changes in R&D activities.
  21. FY2019-Q2RestatedAnnual report

    「The group's total research and development expenses for the six months ended the second quarter of the current fiscal year were ¥250 million. There were no material changes in the status of the group's research and development activities during the six months ended the second quarter of the current fiscal year.」

    ¥250 million in R&D expenses was recognized, and it was stated that there were no material changes in R&D activities.
  22. FY2019-Q1RestatedAnnual report

    「The group's total research and development expenses for the first quarter of the current fiscal year were ¥129 million. There were no material changes in the status of the group's research and development activities during the first quarter of the current fiscal year.」

    The company states that there were no material changes in its R&D activities and reports research and development expenses of ¥129 million for the first quarter.
  23. FY2018-Q3RestatedAnnual report

    「The group's total research and development expenses for the nine months ended the third quarter of the current fiscal year were ¥316 million. There were no material changes in the status of the group's research and development activities during the nine months ended the third quarter of the current fiscal year.」

    The company states that there were no material changes in its R&D activities and reports research and development expenses of ¥316 million for the nine months ended the third quarter.
  24. FY2018-Q2RestatedAnnual report

    「The group's total research and development expenses for the six months ended the second quarter of the current fiscal year were ¥224 million. There were no material changes in the status of the group's research and development activities during the six months ended the second quarter of the current fiscal year.」

    The company states that there were no material changes in its R&D activities and reports research and development expenses of ¥224 million for the six months ended the second quarter.
  25. FY2018-Q1RestatedAnnual report

    「The group's total research and development expenses for the first quarter of the current fiscal year were ¥116 million. There were no material changes in the status of the group's research and development activities during the first quarter of the current fiscal year.」

    The company states that there were no material changes in its R&D activities and reports research and development expenses of ¥116 million for the first quarter.
  26. FY2017AdvancedAnnual report

    「Total research and development expenses for the consolidated fiscal year were ¥463 million. The main research and development activities by segment were as follows. To meet this demand, the group is conducting a proof-of-concept using electronic receivables to acquire blockchain technology, which is core technology for FinTech and has high potential for application in other industries. It is also developing a dynamic verification tool for automotive microcontrollers and in-vehicle networks for the new era.」

    The company recorded ¥463 million in research and development expenses and disclosed specific R&D themes, including blockchain technology validation and a dynamic verification tool for automotive microcontrollers.
  27. FY2017-Q3RestatedAnnual report

    「The company will continue making strategic investments and conducting research and development in areas including FinTech, IoT, AI and the use of big data.」

    The company continues to invest in and conduct research and development in advanced fields including FinTech, IoT, AI and the use of big data.
  28. FY2016First statedAnnual report

    「To meet this demand, the group is conducting research and development of a sales-management solution that runs on the IT infrastructure product “intra-mart Accel Platform (※).”」

    The company lists research and development in several fields, including sales management, housing presentations, broadcast monitoring, automotive microcontrollers and embedded-device visualisation.
Moved together

"Creation of New Solutions and Investment in Advanced Fields" moved the same way as this thread, in the same document, in 5 of its 28 moves.

554444★123456
  1. ★This thread
  2. 1Creation of New Solutions and Investment in Advanced Fields5×
  3. 2Implementation of Dividend Increase and Share Repurchases5×
  4. 3Strengthening Solution-Based Sales and New-Market Development4×
  5. 4Revenue and profit growth targets4×
  6. 5Risk Management and Group Internal Controls4×
  7. 6Promoting ESG and Visualizing Contributions to the SDGs4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Dts's next results are scheduled for 2026-11-02. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
R&D for Competitive Solutions | DTS CORPORATION (9682) | Komori